TNRC6A and infection: We then evaluated whether the differences in targeting against EDI and EDII were related to genotypic differences between the human challenge Tonga ’74 strain (X54319) and a representative strain of circulating DENV2 in our natural infection cohort (MG895171) (Fig. 7C; Fig. S6).